Translational research facilitates the movement of new ideas and treatments from the laboratory to the clinic, as well as the movement of clinical observations from the clinic to the laboratory.
Transcending boundaries
When new questions arise in the clinic, the seamless collaboration of our teams allows clinicians and scientists to identify and test new hypotheses, together, at a speed unmatched in our field. This unique cycle of discovery allows for new findings to be validated within a patient population of extensive scale and complexity.
Spotlight on an innovative treatment plan
Heather Williams was 24 years old and seven weeks pregnant when she was diagnosed with stage IV renal medullary carcinoma, rare and extremely aggressive kidney cancer. Her care team crafted an innovative care plan to save both Heather and her baby. “Without research, I wouldn’t be here,” Heather said. “My baby wouldn’t be here. It’s as simple as that."
To do something that nobody else has ever thought of or done before, based on research, and it’s successful, that’s beautiful.
Featured Translational Research Labs
Heymach Laboratory
Molecular drivers of non-small cell lung cancer
Gibbons Laboratory
Regulation of cancer cell invasion, metastasis by microRNAs
Cascone Laboratory
Tumor response and resistance to immune checkpoint therapies
Wargo Laboratory
The role of the gut microbiome in response to immunotherapy
Translational Research Resources
Our researchers have access to state-of-the-art equipment, NCI-designated programs of research excellence and research centers and programs that promote collaboration.
Related Departments and Programs
-
Investigational Cancer Therapeutics
-
Therapeutics Discovery
-
Clinical and Translational Research Center
-
Center for Clinical & Translational Sciences
-
Center for Community-Engaged Translational Research
-
Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms
-
Platform for Innovative Microbiome and Translational Research
-
Translational Molecular Pathology
Collaborations
MD Anderson and Sibylla Biotech announce strategic collaboration to discover and develop small-molecule protein degraders
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines
